Zofran Heart Defects
Studies suggest link between Zofran use in pregnancy and babies with heart defects
Research has indicated that Zofran, an anti-nausea medication manufactured by GlaxoSmithKline, mothers who take the medicine during pregnancy are two times more likely to have a baby with a serious heart defect than mothers who were not exposed to Zofran. As research continues, more studies suggest a link between Zofran use in pregnancy and babies born with serious heart defects.
The law firm of Bernstein Liebhard LLP is reviewing nationwide legal claims alleging Zofran heart defects in newborns. You may be eligible to file a legal claim for compensation if you consumed Zofran to help treat nausea and vomiting while you were pregnant and your baby was born with-
- Atrial Septal Defect
- Ventricular Septal Defect
- Heart Murmur
When babies are born with heart defects, they may need extended cardiovascular medical care and may still suffer health issues for the rest of their lives. If you were pregnant and used Zofran to help treat nausea and vomiting, and your baby was born with a heart defect, you may be eligible for compensation from the drug manufacturer to help you recover the costs of past and future medical bills, as well as damages for lost wages and your families pain and suffering. If you believe your baby was born with a heart defect because of this anti-nausea medication and you want to file a Zofran heart defect lawsuit call our office today to arrange a free and confidential case review.
Zofran and Heart Defects in Babies
Zofran is approved by the U.S. Food and Drug Administration as a treatment for vomiting and nausea in patients undergoing certain cancer treatments and for postoperative patients. Zofran has not been approved by the FDA for the treatment of nausea and vomiting in pregnancy (NVP) though it is increasingly being used off-label for that treatment.
Research has suggested that taking Zofran for morning sickness can increase the risk of babies being born with heart defects. In fact, a study that analyzed data collected from a Danish registry found in 2013 that babies born to mothers who took Zofran during the pregnancy had a 30 percent greater risk of birth defects, and a two-fold greater risk of being born with heart defects.
In 2014, Reproductive Toxicology published a study indicating that taking Zofran during pregnancy may double the risks of newborn heart defects.
The Toronto Star reported in 2014 that heart defects suffered by babies exposed to Zofran in the womb include –
- Ventricular Septal Defect where the wall between the bottom chambers of the heart has a hole
- Atrial Septal Defect where the wall between the upper chambers of the heart has a whole
- Heart Murmur where blood can be heard with a stethoscope swooshing around the heart, sometimes caused by heart valve problems or high heart rates among other things.
In 2015, a case study published in Pediatric Emergency Care in January analyzed the heart-related deaths of two children who received Zofran while they had the stomach flu. This study suggests that taking Zofran could be deadly for children who may have an increased risk for cardiovascular issues.
Legal Help for Babies Suffering Zofran Heart Defects
If you or your loved one consumed Zofran during their pregnancy for morning sickness and your newborn suffers from a heart defect, contact the Zofran heart defects attorneys at Bernstein Liebhard LLP today. You may be eligible to file a Zofran lawsuit against GlaxoSmithKline to hold them accountable for the injuries caused to your baby. To learn more about filing a Zofran lawsuit and your rights under the law, call us today at 1-844-4-ZOFRAN.